Furthermore, FOXI1 is selectively expressed in intercalated cells (ICs), the putative cellular origin of chRCC36,50 and is more highly expressed in chRCC than other cancer subtypes in the TCGA dataset (Supplementary Fig. S7A). Here, FOXI1 is linked to cancer.